Page last updated: 2024-10-30

mecamylamine and Acute Lung Injury

mecamylamine has been researched along with Acute Lung Injury in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kox, M1
Pompe, JC1
Peters, E1
Vaneker, M1
van der Laak, JW1
van der Hoeven, JG1
Scheffer, GJ1
Hoedemaekers, CW1
Pickkers, P1

Other Studies

1 other study available for mecamylamine and Acute Lung Injury

ArticleYear
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
    British journal of anaesthesia, 2011, Volume: 107, Issue:4

    Topics: Acute Lung Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cholines

2011